Please login to the form below

Not currently logged in
Email:
Password:

Wockhardt aims for US takeover target

India-headquartered Wockhardt is in the final stages of acquiring US-based Morton Grove Pharmaceuticals

India-headquartered pharmaceutical company Wockhardt is in the final stages of acquiring US-based Morton Grove Pharmaceuticals, according to The Economic Times of India.

So far, Wockhardt has declined to comment on the development, but sources close to the newspaper said the deal could be in the range of USD 50m to USD 70m.

US sales currently contribute around nine per cent toward Wockhardt's revenue (approx. INR 2bn/ USD 50.8m), while Europe contributes 52 per cent.

Wockhardt's chairman Habil Khorakiwala told the Economic Times that the company was aiming to increase its revenue from the US three to four times by 2009 and that it was looking at acquisitions in the region to achieve scale.

Morton Grove employs about 300 people and manufactures and markets over 50 products in the liquid generic pharmaceuticals market. The company currently has about 11 generic drug applications under regulatory review, while it also has over 30 oral liquid, topical liquid and prescription nasal spray products in the pipeline which are scheduled to enter the market as the branded patents expire.

Wockhardt markets 21 products, including six injectable treatments, in the US under its own brand. The company is the largest Indian drug maker in the EU, with 1,500 employees and over 130 products. In H1 FY07, US product revenue was INR 1bn (USD 25.4m).

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics